vs
西蒙地产集团（ELS）与Ultragenyx Pharmaceutical Inc.（RARE）财务数据对比。点击上方公司名可切换其他公司
西蒙地产集团的季度营收约是Ultragenyx Pharmaceutical Inc.的1.9倍（$397.6M vs $207.3M），Ultragenyx Pharmaceutical Inc.同比增速更快（25.9% vs 2.7%），过去两年Ultragenyx Pharmaceutical Inc.的营收复合增速更高（38.0% vs 2.3%）
西蒙地产集团是美国头部房地产投资信托企业，投资范围涵盖购物中心、奥特莱斯及社区生活中心等商业地产业态，是美国规模最大的购物中心持有方，总部位于印第安纳州印第安纳波利斯，截至2024年12月末共持有232处物业权益。
Ultragenyx Pharmaceutical Inc.是一家总部位于美国的生物制药企业，专注于研发罕见病和超罕见遗传病的创新治疗方案，这类疾病目前大多无获批疗法，存在大量未被满足的临床需求。公司覆盖生物制剂、小分子药物、基因疗法、反义寡核苷酸及mRNA等多种药物技术平台，研发管线涵盖骨骼、内分泌、代谢、肌肉及中枢神经系统疾病领域。
ELS vs RARE — 直观对比
营收规模更大
ELS
是对方的1.9倍
$207.3M
营收增速更快
RARE
高出23.2%
2.7%
两年增速更快
RARE
近两年复合增速
2.3%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $397.6M | $207.3M |
| 净利润 | — | $-128.6M |
| 毛利率 | — | — |
| 营业利润率 | — | -54.7% |
| 净利率 | — | -62.0% |
| 营收同比 | 2.7% | 25.9% |
| 净利润同比 | — | 3.5% |
| 每股收益（稀释后） | $0.56 | $-1.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ELSRARE
| Q1 26 | $397.6M | — | ||
| Q4 25 | $373.9M | $207.3M | ||
| Q3 25 | $393.3M | $159.9M | ||
| Q2 25 | $376.9M | $166.5M | ||
| Q1 25 | $387.3M | $139.3M | ||
| Q4 24 | $372.3M | $164.6M | ||
| Q3 24 | $387.3M | $139.5M | ||
| Q2 24 | $380.0M | $147.0M |
净利润ELSRARE
| Q1 26 | — | — | ||
| Q4 25 | $103.8M | $-128.6M | ||
| Q3 25 | $100.4M | $-180.4M | ||
| Q2 25 | $83.5M | $-115.0M | ||
| Q1 25 | $114.4M | $-151.1M | ||
| Q4 24 | $100.6M | $-133.2M | ||
| Q3 24 | $86.9M | $-133.5M | ||
| Q2 24 | $82.1M | $-131.6M |
营业利润率ELSRARE
| Q1 26 | — | — | ||
| Q4 25 | 26.5% | -54.7% | ||
| Q3 25 | 25.1% | -106.9% | ||
| Q2 25 | 22.3% | -64.8% | ||
| Q1 25 | 28.3% | -102.6% | ||
| Q4 24 | 27.2% | -74.3% | ||
| Q3 24 | 21.4% | -94.6% | ||
| Q2 24 | 21.5% | -79.1% |
净利率ELSRARE
| Q1 26 | — | — | ||
| Q4 25 | 27.8% | -62.0% | ||
| Q3 25 | 25.5% | -112.8% | ||
| Q2 25 | 22.2% | -69.0% | ||
| Q1 25 | 29.5% | -108.5% | ||
| Q4 24 | 27.0% | -80.9% | ||
| Q3 24 | 22.4% | -95.7% | ||
| Q2 24 | 21.6% | -89.5% |
每股收益（稀释后）ELSRARE
| Q1 26 | $0.56 | — | ||
| Q4 25 | $0.52 | $-1.28 | ||
| Q3 25 | $0.50 | $-1.81 | ||
| Q2 25 | $0.42 | $-1.17 | ||
| Q1 25 | $0.57 | $-1.57 | ||
| Q4 24 | $0.51 | $-1.34 | ||
| Q3 24 | $0.44 | $-1.40 | ||
| Q2 24 | $0.42 | $-1.52 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $421.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $1.8B | $-80.0M |
| 总资产 | $5.7M | $1.5B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ELSRARE
| Q1 26 | — | — | ||
| Q4 25 | — | $421.0M | ||
| Q3 25 | — | $202.5M | ||
| Q2 25 | — | $176.3M | ||
| Q1 25 | — | $127.1M | ||
| Q4 24 | — | $174.0M | ||
| Q3 24 | — | $150.6M | ||
| Q2 24 | — | $480.7M |
总债务ELSRARE
| Q1 26 | — | — | ||
| Q4 25 | $3.3B | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $3.2B | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
股东权益ELSRARE
| Q1 26 | $1.8B | — | ||
| Q4 25 | $1.8B | $-80.0M | ||
| Q3 25 | $1.8B | $9.2M | ||
| Q2 25 | $1.7B | $151.3M | ||
| Q1 25 | $1.7B | $144.2M | ||
| Q4 24 | $1.7B | $255.0M | ||
| Q3 24 | $1.4B | $346.8M | ||
| Q2 24 | $1.4B | $432.4M |
总资产ELSRARE
| Q1 26 | $5.7M | — | ||
| Q4 25 | $5.7B | $1.5B | ||
| Q3 25 | $5.7B | $1.2B | ||
| Q2 25 | $5.7B | $1.3B | ||
| Q1 25 | $5.6B | $1.3B | ||
| Q4 24 | $5.6B | $1.5B | ||
| Q3 24 | $5.6B | $1.5B | ||
| Q2 24 | $5.6B | $1.6B |
负债/权益比ELSRARE
| Q1 26 | — | — | ||
| Q4 25 | 1.91× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 1.84× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $-99.8M |
| 自由现金流经营现金流 - 资本支出 | — | $-100.8M |
| 自由现金流率自由现金流/营收 | — | -48.6% |
| 资本支出强度资本支出/营收 | — | 0.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-472.0M |
8季度趋势，按日历期对齐
经营现金流ELSRARE
| Q1 26 | — | — | ||
| Q4 25 | $571.1M | $-99.8M | ||
| Q3 25 | $147.0M | $-91.4M | ||
| Q2 25 | $131.3M | $-108.3M | ||
| Q1 25 | $193.4M | $-166.5M | ||
| Q4 24 | $596.7M | $-79.3M | ||
| Q3 24 | $149.5M | $-67.0M | ||
| Q2 24 | $143.1M | $-77.0M |
自由现金流ELSRARE
| Q1 26 | — | — | ||
| Q4 25 | $334.1M | $-100.8M | ||
| Q3 25 | $75.7M | $-92.7M | ||
| Q2 25 | $71.8M | $-110.7M | ||
| Q1 25 | $148.2M | $-167.8M | ||
| Q4 24 | $355.4M | $-79.5M | ||
| Q3 24 | $91.1M | $-68.6M | ||
| Q2 24 | $80.6M | $-79.0M |
自由现金流率ELSRARE
| Q1 26 | — | — | ||
| Q4 25 | 89.4% | -48.6% | ||
| Q3 25 | 19.3% | -58.0% | ||
| Q2 25 | 19.1% | -66.5% | ||
| Q1 25 | 38.3% | -120.5% | ||
| Q4 24 | 95.5% | -48.3% | ||
| Q3 24 | 23.5% | -49.2% | ||
| Q2 24 | 21.2% | -53.7% |
资本支出强度ELSRARE
| Q1 26 | — | — | ||
| Q4 25 | 63.4% | 0.5% | ||
| Q3 25 | 18.1% | 0.8% | ||
| Q2 25 | 15.8% | 1.5% | ||
| Q1 25 | 11.7% | 1.0% | ||
| Q4 24 | 64.8% | 0.1% | ||
| Q3 24 | 15.1% | 1.2% | ||
| Q2 24 | 16.5% | 1.4% |
现金转化率ELSRARE
| Q1 26 | — | — | ||
| Q4 25 | 5.50× | — | ||
| Q3 25 | 1.46× | — | ||
| Q2 25 | 1.57× | — | ||
| Q1 25 | 1.69× | — | ||
| Q4 24 | 5.93× | — | ||
| Q3 24 | 1.72× | — | ||
| Q2 24 | 1.74× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ELS
| Rental income | $339.0M | 85% |
| Other | $37.2M | 9% |
| Annual membership subscriptions | $18.3M | 5% |
| Membership upgrade revenue | $3.1M | 1% |
RARE
| Royalty | $105.6M | 51% |
| Products | $101.7M | 49% |
